Aurinia Pharmaceuticals Aktie
WKN: A1W7D4
ISIN: CA05156V1022
Land: Kanada
Branche: Chemie, Pharma, Bio- & Medizintechnik
Sektor: Pharma
9,84 EUR -0,18 EUR -1,80 %
22:59:51 L&S RT
boerse.de-
Aktien-
Rating:

(Info)
B
Neu

Weshalb die Aurinia Pharmaceuticals-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 08. August 2025 Info.

Komplette Navigation anzeigen

Statistik Aurinia Pharmaceuticals seit 31.05.2001

Aurinia Pharmaceuticals Aktie: Die besten Jahre

Rang Datum Vorjahr Schluss Performance
1 2013 0,3000 2,3900 696,67%
2 2019 5,1600 18,5000 258,53%
3 2010 2,8000 7,4500 166,07%
4 2023 3,4300 8,1900 138,78%
5 2009 1,2500 2,8000 124,00%
6 2017 1,9800 3,7600 89,90%
7 2021 11,1000 19,7700 78,11%
8 2018 3,7600 5,1600 37,23%
9 2014 2,3900 2,8800 20,50%
10 2025 8,6200 9,8500 14,27%
11 2005 63,0000 68,5000 8,73%
12 2024 8,1900 8,6200 5,25%
13 2003 92,5000 87,5000 -5,41%
14 2016 2,3100 1,9800 -14,29%
15 2015 2,8800 2,3100 -19,79%
16 2006 68,5000 53,5000 -21,90%
17 2004 87,5000 63,0000 -28,00%
18 2020 18,5000 11,1000 -40,00%
19 2007 53,5000 30,2000 -43,55%
20 2002 165,0000 92,5000 -43,94%

Aurinia Pharmaceuticals Aktie: Die schlechtesten Jahre

Rang Datum Vorjahr Schluss Performance
1 2008 30,2000 1,2500 -95,86%
2 2012 2,1500 0,3000 -86,05%
3 2022 19,7700 3,4300 -82,65%
4 2011 7,4500 2,1500 -71,14%
5 2002 165,0000 92,5000 -43,94%
6 2007 53,5000 30,2000 -43,55%
7 2020 18,5000 11,1000 -40,00%
8 2004 87,5000 63,0000 -28,00%
9 2006 68,5000 53,5000 -21,90%
10 2015 2,8800 2,3100 -19,79%
11 2016 2,3100 1,9800 -14,29%
12 2003 92,5000 87,5000 -5,41%
13 2024 8,1900 8,6200 5,25%
14 2005 63,0000 68,5000 8,73%
15 2025 8,6200 9,8500 14,27%
16 2014 2,3900 2,8800 20,50%
17 2018 3,7600 5,1600 37,23%
18 2021 11,1000 19,7700 78,11%
19 2017 1,9800 3,7600 89,90%
20 2009 1,2500 2,8000 124,00%

Aktualisiert und erweitert!